This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

FEI Company's CEO Presents At Goldman Sachs Healthcare Conference (Transcript)

FEI Company (FEIC)

Goldman Sachs Healthcare Conference Call

June 05, 2012 05:40 pm ET

Executives

Don Kania - President & CEO

Analysts

Isaac Ro - Goldman Sachs

Presentation

Isaac Ro - Goldman Sachs



Okay. All right let's get started. Thanks all of you guys for after lunch sticking around and beautiful weather, its good. Isaac Ro from Life Sciences here at Goldman, very happy to have Don Kania from FEI with us today and we actually think this is a company that has really only in the last year or so come back on the radar screen and named it that investors in this part of the world tend to know much about. So thanks for coming. And secondly, if we could have you maybe sort of a couple of minutes going over the big picture story on your key initiatives for this year and I think if we can start here and we can just jump into questions from there.

Don Kania

Okay, sure. For those you who don't know we are a company that makes electron microscopes, very sophisticated microscope that can see very, very small things and that's the starting point. Our thesis is technology leadership in providing total solutions to a market oriented set of customers and so we organize ourselves around marketplaces one of which is life sciences which fits into the theme of today's meeting, but we also serve the electronics business which is semiconductor customers.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs